Federal efforts to bring greater transparency to pharmacy benefit manager (“PBM”) compensation are advancing. On October 29, 2026, the Department of Labor (“DOL”) released its final PBM compensation disclosure rule for large, self-insured ERISA health plans (“Final Rule”).1 Together with the CAA’s separate employer plan requirements, these developments should give plan sponsors substantially greater visibility into PBM economics. Sheppard has distilled the essentials of what PBMs2 and affected health plans need to know.
The PBM Transparency Saga
DOL published its proposed PBM disclosure rule on January 30, 2026, responding to an April 2025 executive order directing greater transparency into PBM compensation.3 Congress then enacted the CAA on February 3, adding its own PBM reporting and pass-through requirements and expanding ERISA’s statutory compensation disclosure provisions.4 DOL subsequently extended its comment period to April 15 to give stakeholders an opportunity to address